Mechanism of As2O3-Induced Action Potential Prolongation and Using hiPS-CMs to Evaluate the Rescue Efficacy of Drugs With Different Rescue Mechanism
Mechanism of As2O3-Induced Action Potential Prolongation and Using hiPS-CMs to Evaluate the Rescue Efficacy of Drugs With Different Rescue Mechanism
复制标题
As2O3诱导动作电位延长的机制及利用hiPS-CM评价不同解救机制药物的解救效果
DOI:
10.1093/toxsci/kfx098
复制
发表时间:
2017-08
影响因子:
3.8
通讯作者:
Li Baoxin
中科院分区:
文献类型:
--
作者:
Yan Meng;Feng Lifang;Shi Yanhui;Wang Junnan;Liu Yan;Li Fengmei;Li Baoxin
Arsenic trioxide (As2O3) has been verified as a breakthrough in the management of acute promyelocytic leukemia in recent decades. However, cardiotoxicity, especially long QT syndrome (LQTS) has become the most important issue during As2O3 treatment. The characterized mechanisms behind this adverse effect are inhibition of cardiac hERG channel trafficking and increase of cardiac calcium currents. In our study, we found a new pathway underlying As2O3-induced cardiotoxicity that As2O3 accelerates lysosomal degradation of hERG on plasma membrane after using brefeldin A (BFA) to block protein trafficking. Then we explored pharmacological rescue strategies on As2O3-induced LQTS, and found that 4 therapeutic agents exert rescue efficacy via 3 different pathways: fexofenadine and astemizole facilitate hERG trafficking via promotion of channel-chaperone formation after As2O3 incubation; ranolazine slows hERG degradation in the presence of As2O3; and resveratrol shows significant attenuation on calcium current increase triggered by As2O3. Moreover, we used human-induced pluripotent stem cell derived cardiomyocytes (hiPS-CMs) to evaluate the rescue effects of the above agents on As2O3-induced prolongation of action potential duration (APD) and demonstrated that fexofenadine and resveratrol significantly ameliorate the prolonged APD. These observations suggested that pharmacological chaperone like fexofenadine and resveratrol might have the potential to protect against the cardiotoxicity of As2O3.
登录
查看更多内容
DOI:
10.1016/j.yjmcc.2007.03.024
发表时间:
2006-02
影响因子:
3.1
作者:
通讯作者:
--
影响因子:
20.1
作者:
Zhang J;Wilson GF;Soerens AG;Koonce CH;Yu J;Palecek SP;Thomson JA;Kamp TJ
通讯作者:
Kamp TJ
影响因子:
4.8
作者:
Ficker, E;Obejero-Paz, CA;Brown, AM
通讯作者:
Brown, AM
影响因子:
2.1
作者:
Naito, Kensuke;Kobayashi, Miki;Ohnishi, Kazunori
通讯作者:
Ohnishi, Kazunori
影响因子:
7.3
作者:
Zhao, X-Y;Li, G-Y;Yang, B-F
通讯作者:
Yang, B-F